Status:
ACTIVE_NOT_RECRUITING
Decreasing Cardiovascular Risk for Patients With Diabetes
Lead Sponsor:
Michigan State University
Collaborating Sponsors:
University of Michigan
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cardiovascular disease (CVD) complications are the leading cause of diabetes mellitus (DM)-related morbidity and mortality, creating a significant burden on the public health system. This burden is, i...
Detailed Description
Study design and overview: The investigators will conduct this study with 17 teams in 12 clinics that serve low-income patients: Federally Qualified Health Centers (FQHC's). The goal of the study is t...
Eligibility Criteria
Inclusion
- Patients: aged \>18 at participating Federally Qualified Health Care centers (FQHCs) and; 1) have a diagnosis of Type 2 diabetes (T2DM) with HbA1c \>8, with or without CVD; 2) patient should be taking at least one prescribed medication for BP or cholesterol management 3) able to provide informed consent 4) able to read and speak English (grade 6 reading level); 5) have a cell phone with texting (provided by our study for any enrolled patient who does not have one).
Exclusion
- 1\) medical record documentation of cognitive impairment, dementia or psychosis 2) plans to leave the area prior to study completion 3) participating in another cellphone program.
Key Trial Info
Start Date :
May 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
378 Patients enrolled
Trial Details
Trial ID
NCT04874116
Start Date
May 26 2021
End Date
September 30 2026
Last Update
September 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ingham Healthcare center
Lansing, Michigan, United States, 48742